Johne's Disease Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Goat, Sheep), By Test Type (ELISA, PCR, AGID), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2022 - 2030

Report Overview

The global Johne’s disease diagnostics market size was valued at USD 0.58 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of over 5.1% from 2022 to 2030. The global trend of digitalization in healthcare has also impacted the animal health industry including Johne’s disease diagnostics. Companies are investing in product development to incorporate better testing accuracy, validating devices, expanding the test menu, and automating the process as much as possible, thus reducing the complexity of operating the device. Point-of-care testing for infectious diseases also presents high-value targets, especially if they affect livestock animals or if the disease is transmissible from animals to people.

The COVID-19 pandemic resulted in a decline in the market for Johne’s disease diagnostics, especially during 2020. This adverse impact is mainly attributable to the closure of and restricted access to veterinary diagnostics due to social distancing norms and lockdowns. During the second and third quarters of 2020, demand steadily recovered as governments began to relax their stay-at-home policies.  Inefficiencies in remote collaboration and field testing were other challenges brought on by the COVID-19 pandemic. The market for Johne’s disease diagnostics is estimated to grow notably over the coming years owing to the increasing demand for easy and rapid diagnostic products and comparatively lax regulatory supervision. The U.S. FDA does not mandate manufacturers who exclusively manufacture or market veterinary devices to list their devices or register their establishments. Overall, the pandemic has had a significant impact on the market.

Some of the key drivers impacting the market for Johne’s disease diagnostics include Johne's disease eradication programs, increasing awareness regarding paratuberculosis, and the rising livestock population. For instance, the Irish Johne's Control Programme (IJCP) is a long-term voluntary control program for Johne's disease (JD) in Ireland, with strong support from the Irish cattle industry. It takes advantage of the formation of Animal Health Ireland to combat animal diseases not covered by EU regulations. Furthermore, it has four goals: prevent the transmission of JD to uninfected farms, reduce the degree of infection when it exists, ensure JD control markets in Ireland, and promote calf health and farm biosecurity.

The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service’s Veterinary Services department (USDA-APHIS-VS) has developed a Johne’s disease curtail program for curbing the spread of the disease to non-infected herds. It has developed a cooperative Federal-State-Industry program for providing producer assistance by performing risk assessments. It is also working on providing funding for research for the development and validation of control measures. Furthermore, the market for Johne’s disease diagnostics is now being supported by constant innovation in the veterinary diagnostics sector.

For example, Zoetis announced the addition of Digital Cytology testing to their VETSCAN IMAGYST platform, which was introduced in September 2020, and in March 2022. VETSCAN IMAGYST now provides access to a network of remote professional clinical diagnosticians as well as AI technologies for fecal testing. Furthermore, veterinary medicine has historically outperformed human treatment in terms of diagnostic results and client calls returned. In-clinic digital cytology scanners from IDEXX and Antech are now advancing the industry's development and productivity by providing quick results, improving client adherence and happiness, and connecting veterinarians to pathologists.

Animal Type Insights

The cattle segment dominated the market for Johne’s disease diagnostics and accounted for the largest revenue share of around 90.0% in 2021. Cows, bulls, oxen, calves, and buffaloes make up this category. Increased zoonotic disease incidence in cattle is likely to drive market expansion. According to the National Library of Medicine, 816 of the 1,407 human diseases in 2019 were zoonotic, meaning they might be spread naturally between animals and people. 538 bacteria and rickettsia, 317 fungi, 208 viruses, 287 helminths, and 57 protozoa were among them. Globally, rising cow and livestock populations are contributing to market expansion.

With over 18 million cattle, beef was the most common livestock farmed in France in 2020. In 2020, pork and beef accounted for over 80% of all cattle farmed in France. The sheep segment is expected to witness the fastest growth rate during the forecast period. Ovine Johne’s disease is caused by infection of the bacteria Mycobacterium paratuberculosis. In Australia, confirmed and suspected cases of ovine Johne’s disease must be reported to Agriculture Victoria’s animal health staff within seven days of identification by owners.

Test Type Insights

The PCR segment dominated the market for Johne’s disease diagnostics and accounted for over 35.0% share of the market. The key factor expected to propel the growth of the segment include the rapid adoption of testing and diagnostic technologies and the rise in the population of livestock will further drive the market. Furthermore, PCR is commonly available at clinical immunology and microbiology laboratories. PCR provides greater sensitivity and becomes positive for an infection earlier than an antibody test. For instance, A Johne's Direct Fecal PCR test is available from the Animal Health Diagnostic Center (AHDC).

For most herds controlling Johne's disease through management treatments and testing, this test is available to veterinary doctors and is designed to change individual cow or goat cultures. The ELISA segment is expected to witness the fastest CAGR over the forecast period owing to the increasing adoption of diagnostic tests. Furthermore, it can only be performed on individual samples and cannot be pooled.

Regional Insights

North America dominated the market for Johne’s disease diagnostics and accounted for the largest revenue share of more than 32.0% in 2021. The high share of the region is owing to the presence of key service providers, the adoption of various strategic initiatives to increase market penetration, and the rising livestock population. Moreover, there has been a noticeable increase in outsourcing activities for biopharmaceutical development in the U.S. Large market share of the U.S. in the Johne’s disease diagnostics market can be attributed to the local presence of major players, such as Thermo Fisher Scientific, Inc., Zoetis, and IDEXX, which are involved in the development and introduction of tests required for the diagnosis of Johne’s disease. Furthermore, collaborations between local and international companies and acquisitions are also expected to fuel market growth in the U.S. For instance, in April 2020, Zoetis completed the acquisition of Performance Livestock Analytics for improving its animal health solutions across the continuum of care for beef producers. 

In the Asia Pacific, the market for Johne’s disease diagnostics is estimated to witness the fastest CAGR of over 5.7% during the projected period. Countries such as China and India are expected to witness rapid market growth owing to an increase in the number of manufacturing facilities in the region. Rising R&D investment by market players for the development of value-added products is anticipated to drive market growth in the region. Moreover, an increase in the number of livestock and the prevalence of zoonotic diseases are expected to boost the market. Thus, the abovementioned factors are anticipated to drive market growth.

Key Companies & Market Share Insights

The market for Johne’s disease diagnostics is competitive and fragmented. Leading companies are involved in deploying strategic initiatives that include service expansion, competitive pricing strategies, sales and marketing initiatives, partnerships, and mergers and acquisitions. For instance, in January 2022, PBD Biotech expanded its business in North America. This supported the company’s regional expansion strategy and furthered its presence in North America. Some of the prominent players in the Johne’s disease diagnostics market include:  

• Thermo Fisher Scientific, Inc.

• PBD Biotech

• Zoetis

• IDEXX Laboratories

• IDVET

• VMRD Inc.

• Biomeriux SA.

Johne’s Disease Diagnostics Market Report Scope 

Segments Covered in the Report

This report forecasts revenue growth at the regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this report, Grand View Research has segmented the Johne’s disease diagnostics Market on the basis of animal type, test type, and region:

• Animal Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Cattle

  • Goat

  • Sheep

• Test Type Outlook (Revenue, USD Million, 2017 - 2030)

  • ELISA

  • PCR

  • AGID

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • Israel